Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.003 USD | +0.16% | -4.15% | -70.07% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.71M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -14M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-0.51
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.58% |
Latest transcript on Processa Pharmaceuticals, Inc.
1 day | +0.16% | ||
1 week | -4.15% | ||
Current month | -8.11% | ||
1 month | +20.67% | ||
3 months | -19.23% | ||
6 months | -76.70% | ||
Current year | -70.07% |
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 11-03-28 |
Sian Bigora
FOU | Founder | 63 | 11-03-28 |
David Young
FOU | Founder | 71 | 11-03-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 23-08-07 |
James Neal
BRD | Director/Board Member | 68 | 22-07-15 |
Justin Yorke
CHM | Chairman | 58 | 17-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 2.003 | +0.16% | 6 296 |
24-05-16 | 2 | -0.99% | 25,548 |
24-05-15 | 2.02 | -7.34% | 110,423 |
24-05-14 | 2.18 | -1.80% | 70,660 |
24-05-13 | 2.22 | +6.22% | 48,080 |
Delayed Quote Nasdaq, May 17, 2024 at 10:03 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.07% | 5.71M | |
+31.91% | 694B | |
+29.55% | 593B | |
-1.68% | 371B | |
+19.29% | 331B | |
+6.51% | 290B | |
+14.21% | 239B | |
-3.07% | 209B | |
+10.03% | 209B | |
+8.28% | 169B |
- Stock Market
- Equities
- PCSA Stock